Merck’s MRK stock has risen 32.3% in the past three months. The stock has also been trading above its 50-day and 200-day ...

Merck is in talks to acquire Revolution Medicines in a deal that could value it at around $30 billion, according to people ...

Merck said on Monday it has raised its outlook for new growth drivers, forecasting $70 billion in revenue from these fresh ...

Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...

US pharmaceutical group Merck is in talks to buy Revolution Medicines, a cancer drugmaker with a market capitalisation of ...

Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the ...

The company’s previous CCO was Cristal Downing, who joined Insulet as chief corporate affairs officer late last year.

A key number for Merck in the coming years is $70 billion. This is the mid-2030s revenue opportunity from potential new ...

RAHWAY, N.J. - Merck is officially adding an experimental flu prevention drug to its portfolio. The New Jersey-based ...

Merck on Thursday said any changes to the U.S. child and adolescent immunization schedule should rest on comprehensive data ...

Dr. Rasha Kelej with Africa First Ladies released “Ray of Hope” - A Storybook and Animation Film to strengthen Cancer ...